DIVI'S LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE3728.70-29.5 (-0.78 %)
PREV CLOSE (Rs.) 3758.20
OPEN PRICE (Rs.) 3758.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2641
TODAY'S LOW / HIGH (Rs.)3722.75 3775.65
52 WK LOW / HIGH (Rs.)2730 3949
NSE3729.75-30.4 (-0.81 %)
PREV CLOSE( Rs. ) 3760.15
OPEN PRICE (Rs.) 3761.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3729.75 (2)
VOLUME 329180
TODAY'S LOW / HIGH(Rs.) 3720.95 3775.95
52 WK LOW / HIGH (Rs.)2730 3934.7
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
99.10
Dividend Yield(%)
0.80
TTM EPS (Rs.)
49.60
P/E Ratio
75.18
Book Value (Rs.)
474.52
Face Value (Rs.)
2
MCap (Rs. in Mn)
989852.69
Price/Earning (TTM)
59.03
Price/Sales (TTM)
13.76
Price/Book (MRQ)
7.86
PAT Margin (%)
23.55
ROCE (%)
19.31
Incorporation Year : 12-10 1990

Management Info :

Ramesh BV Nimmagadda - Chairman Murali K Divi - Managing Director

Registered Office :

Address : 1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone : 040 66966300

Website : www.divislabs.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
16Nov Divi’s Laboratories informs about disc
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obliga..
06Nov Divi's Laboratories reports 29% fall i
Divi's Laboratories has reported results for second quarter ended Septem..
06Nov Divi's Laboratories informs about outc
Divi's Laboratories has informed that the Board of Directors of the Comp..
QTR Sep 23 ANNUAL 23
Net Profit342018081.5
Gross Profit 4640 23541
Operating Profit 5590 26966.9
Net Sales 18680 76253
Rs. in Millions
Dr. Reddy's Lab (BSE)
 5715.55 (0.78%)
M.Cap (Rs. in Cr)95335.50
Concord Biotech (BSE)
 1285.75 (2.51%)
M.Cap (Rs. in Cr)13451.03
Ajanta Pharma (BSE)
 1948.40 (1.43%)
M.Cap (Rs. in Cr)24533.41
Mercury Laboratories (BSE)
 800.00 (3.07%)
M.Cap (Rs. in Cr)96.00
PROMOTERS
51.93%
MUTUAL FUNDS/UTI
13.62%
NON-INSTITUTION
11.73%
FI/BANKS/INSURANCE
7.35%
GOVERNMENT
0%
FII
0%
Attention Investors KYCIPO
add
"Attention Investors

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

.......... Issued in the interest of Investors"

REGISTERED OFFICE

226/1, AJC Bose Road, Trinity, 3rd Floor, Unit No. 3G, Kolkata 700020,India.

Copyrights @ 2015 C AUM Capital Mkt. Pvt. Ltd. All Rights Reserved
Designed , Developed & Content Powered by   Accord Fintech Pvt. Ltd.

AUM Capital Market Pvt Ltd :SEBI Single Registration Number : INZ000185431 [ NSE : CM, FO, CD , BSE CM, FO , CD, MCX(COMMODITY), NSE & BSE COMMODITY, Registered Member Code: 12764 (NSE), 3180(BSE), 56505 (MCX). AMFI ARN. No. 64606 Depository Participant : NSDL : DP Id: IN304211, CDSL: SEBI Registration no. : IN-DP-CDSL-479-2008 DP Id: 12057800. Research Analyst SEBI Registration no.: INH300002423 CIN: U67120WB2005PTC103417
FOR ANY GRIEVANCE OR INVESTOR COMPLAINT, PLEASE MAIL US AT helpdesk@aumcap.com
Aum Capital Market Pvt. Ltd. is a distributor of Mutual Fund & IPOs.Investment in Securities is subject to market risk.

VISIT COUNT     488635

CLOSE X

Filling complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filling complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances